【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Pomalyst/ Imnovid
04.1.2 Revlimid
04.1.3 Zometa
04.1.4 Doxil/Caelyx
04.1.5 Thalomid/ Thalidomide Celgene
04.1.6 Kyprolis
04.1.7 Mozobil
04.1.8 Velcade
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding Multiple Myeloma
07.2 Pathophysiology
07.3 Epidemiology
07.4 Diagnosis
07.5 Staging
07.6 Management
07.7 Economic Burden
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
10.Market Segmentation by Dosage Form
10.1 Solid
10.2 Liquid
11.Geographical Segmentation
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Pipeline Portfolio
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Celgene
20.2.2 Johnson & Johnson
20.2.3 Novartis
20.2.4 Onyx
20.2.5 Sanofi
20.2.6 Takeda Pharmaceutical
20.3 Other and Future Prominent Vendors
21.Key Vendor Analysis
21.1 Celgene
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Strategy
21.1.4 Business Segmentation by Revenue
21.1.5 Sales by Geography
21.1.6 Key Information
21.1.7 SWOT Analysis
21.2 Johnson & Johnson
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Novartis
21.3.1 Key Facts
21.3.2 Business Description
21.3.3 Business Segmentation
21.3.4 Revenue by Business Segmentation
21.3.5 Revenue Comparison 2012 and 2013
21.3.6 Sales by Geography
21.3.7 Business Strategy
21.3.8 Key Developments
21.3.9 SWOT Analysis
21.4 Onyx Pharmaceuticals
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Marketed Products
21.4.4 Geographical Segmentation
21.4.5 Business Strategy
21.4.6 Recent Developments
21.4.7 SWOT Analysis
21.5 Sanofi
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2013
21.5.4 Business Segmentation by Revenue 2012 and 2013
21.5.5 Geographical Segmentation by Revenue 2013
21.5.6 Business Strategy
21.5.7 Key Developments
21.5.8 SWOT Analysis
21.6 Takeda Pharmaceutical
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Business Segmentation by Revenue 2013
21.6.4 Business Segmentation by Revenue 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Pathophysiology of Multiple Myeloma
Exhibit 3: Indicators of Multiple Myeloma
Exhibit 4: Laboratory Tests to Identify Multiple Myeloma
Exhibit 5: Diagnosis of Multiple Myeloma
Exhibit 6: Staging of Multiple Myeloma
Exhibit 7: Management of Multiple Myeloma
Exhibit 8: Induction Therapy Recommendations for the Transplant Eligible Candidates
Exhibit 9: Maintenance Therapy for the Candidates with Multiple Myeloma
Exhibit 10: Supportive Therapy for the Candidates with Multiple Myeloma
Exhibit 11: Estimated Expenditure for the Four Type of Treatment Regimens for Multiple Myeloma in the US
Exhibit 12: Snapshot of the Economic Burden of Multiple Myeloma
Exhibit 13: Snapshot of Global Multiple Myeloma Drugs Market 2014
Exhibit 14: Global Multiple Myeloma Drugs Market 2014-2019 (US$ million)
Exhibit 15: Global Multiple Myeloma Drugs Market Segmentation By Route Of Administration
Exhibit 16: Global Multiple Myeloma Drugs Market Segmentation by Route of Administration 2014
Exhibit 17: Global Multiple Myeloma Drugs Market Segmentation by Dosage Form
Exhibit 18: Global Multiple Myeloma Drugs Market Segmentation by Dosage Form 2014
Exhibit 19: Global Multiple Myeloma Drugs Market by Geographical Segmentation 2014
Exhibit 20: Buying Criteria of Global Multiple Myeloma Drugs Market 2014
Exhibit 21: Growth Drivers of the Global Multiple Myeloma Drugs Market
Exhibit 22: Drivers and their Impact on the Key Customer Category of Global Multiple Myeloma Drugs Market 2014
Exhibit 23: Drivers and their Impact on the Geographies of Global Multiple Myeloma Drugs Market 2014
Exhibit 24: Challenges of the Global Multiple Myeloma Drugs Market
Exhibit 25: Trends of the Global Multiple Myeloma Drugs Market
Exhibit 26: Phase III Pipeline Molecules for Multiple Myeloma
Exhibit 27: Global Multiple Myeloma Drugs Market Share Analysis 2014
Exhibit 28: Sales Forecast of Pomalyst 2014-2018 (US$ million)
Exhibit 29: YoY Sales Comparison of Revlimid 2007-2013 (US$ million)
Exhibit 30: Sales Forecast of Revlimid 2014-2018 (US$ million)
Exhibit 31: YoY Sales Comparison of Thalomid 2007-2013 (US$ million)
Exhibit 32: Sales Forecast of Thalomid 2014-2018 (US$ million)
Exhibit 33: YoY Sales Comparison of Velcade outside the US 2008-2013 (US$ million)
Exhibit 34: Sales Comparison of Zometa in the US and ROW 2007-2013 (US$ million)
Exhibit 35: Global YoY Sales Comparison of Zometa 2007-2013 (US$ million)
Exhibit 36: YoY Sales Comparison of Zometa in the US 2007-2013 (US$ million)
Exhibit 37: YoY Sales Comparison of Zometa in ROW 2007-2013 (US$ million)
Exhibit 38: Sales Forecast of Kyprolis 2014-2018 (US$ million)
Exhibit 39: Global YoY Sales Comparison of Mozobil 2007-2013 (US$ million)
Exhibit 40: Global YoY Sales Comparison of Velcade in Japan 2009-2013 (US$ million)
Exhibit 41: Sales Forecast of Velcade 2014-2018 (US$ million)
Exhibit 42: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 43: Celgene: Sales by Geography 2013
Exhibit 44: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 45: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 46: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 47: Novartis AG: Business Segmentation
Exhibit 48: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 49: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 50: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 51: Onyx Pharmaceuticals: Marketed Products
Exhibit 52: Onyx Pharmaceuticals: Geographical Segmentation
Exhibit 53: Sanofi: Business Segmentation by Revenue 2013
Exhibit 54: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 55: Sanofi: Geographical Segmentation by Revenue 2013
Exhibit 56: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013
Exhibit 57: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013 (US$ million)
Exhibit 58: Takeda Pharmaceuticals: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：多発性骨髄腫治療薬の世界市場■ 英文：Global Multiple Myeloma Drugs Market 2015-2019
■ 発行日：2014年12月3日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4753
■ 調査対象地域：グローバル
- 無線センサの世界市場：温度センサ、圧力センサ、レベルセンサ、流量センサ、湿度センサ、バイオセンサ、ガスセンサ、監視センサ、モーションセンサAbout wireless sensors Wireless sensors are equipped with transmitters that read signals from instruments or environment and convert them into radio signals. These sensors are considered to be the standard measurement tools that convert wireless signals into data, which can be analyzed. The optimization of technology has resulted in these sensors getting lighter, smaller, smarter, more power effic …
- 移行上皮癌(尿路上皮癌)(Transitional Cell Cancer (Urothelial Cell Cancer))：治療薬開発パイプライン動向（2015年上半期版）Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the Transitional Cell Cancer (Urothelial Cell Cancer)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Transitional Cell Cancer ( …
- Endocarditis：グローバル臨床試験レビューH2, 2013Endocarditis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Endocarditis Global Clinical Trials Review, H2, 2013" provides data on the Endocarditis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endocarditis. It includes an overview of the trial numbers and their recruitment status as per the sit …
- ヨーロッパのジュース市場：フルーツジュース、ネクター、果実飲料、野菜ジュースThe juice market in Europe is expected to decline because of the high sugar content in juice drinks. Technavio's market research analysts estimate the market to reach more than USD 32 billion in revenues by 2019. In terms of consumption, the juice market in Europe was estimated to be close to 19 billion liters in 2014. Orange and apple juices together constituted the major share of juice consumpti …
- 顔認識の世界市場：技術別（2D、3D、顔の分析）、用途別（金融サービス・銀行、国家防衛、政府、小売、軍用、その他）、地域別予測Global Facial Recognition Market to reach USD XXX billion by 2025. Global Facial Recognition Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets are growing security requirements in government sectors for employee attendance and identification. F …
- 組み込みプロセッサの世界市場：MCU、エンベデッドMPU、エンベデッドDSPAbout embedded processors An embedded processor is a type of microprocessor that consists of a variety of discrete chips embedded in one system to perform multiple functions. Embedded processors include dedicated computing cores, memory, and programmable input/output peripherals. They consume less power and are cost effective and compact in size. They are integrated into devices to handle multiple …
- 世界のDNAワクチンパイプライン分析The global market for DNA vaccines is currently recording significant growth rates owing to the lesser side effects, ease of development, lesser cost and continued development in biotechnology arena. At present, not even a single DNA vaccine has been approved for human beings. However, around 100 products are under clinical trial for treating diseases like HIV infection, cancer and other infectiou …
- 世界のオンライン広告市場状況：検索広告、ディスプレイ広告、モバイル広告、RTB、SNS、ビデオ広告n/a
- 世界のPasta and Noodles市場：M&A動向（2014年4月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global pasta & noodles market during April 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global pasta & noodles market throughout the month. Additionally, the report provides an overview of al …
- 室内空気品質（IAQ）モニターの世界市場予測：固定式IAQモニター、携帯式IAQモニターThe global indoor air quality monitor market (IAQM) is expected to be valued at USD 4.63 Billion by 2022, growing at a CAGR of 9.22% during the forecast period. Supportive government regulations for effective indoor air pollution monitoring and control, growing popularity of smart homes/green buildings, ongoing government initiatives toward the development of environment-friendly industries, incre …
- ブルー・バイオテクノロジーの世界市場2019-2023About this market The driving factors of the global blue biotechnology market is the increasing commercial use in the different fields. This is one of the driving factor that will trigger the growth of global blue biotechnology market during the forecast period. Applications of blue technology range over several fields like health care, plant biology, water treatment, research and production of su …
- 世界の自動車外観用化学品市場2015The Global Automotive Aftermarket Appearance Chemicals Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Automotive Aftermarket Appearance Chemicals industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Automotive Aftermarket Appearance Chemicals market …
- 世界のモジュラー型データセンター市場(2014 – 2019)Organizations dealing with large amount of data are looking for solutions to optimize their Power Usage Effectiveness (PUE), as well as quick capacity addition deployments. The solution offered to cater to the needs of data center operators is Modular Data Center, an approach for reengineering and constructing flexible and energy efficient data centers. The modular architecture used in Modular dat …
- 高視認性服の世界市場2016-2020About High-Visibility Clothing High-visibility clothing, a sub-segment of protective clothing in the personal protective equipment (PPE) industry, is worn to alert vehicle operators and drivers of the presence of the worker in low-light or poor-visibility environment. High-visibility clothing is compulsory when the workers are working around moving vehicles like cars, trucks, or other machinery li …
- 糖尿病治療薬の世界市場2016-2026Treating diabetes – benefit your influence by finding new R&D trends and sales prospects Discover the future of antidiabetic medicines. For those treatments, you will receive diabetes market size and revenue projections. You will learn the future potential by exploring research and development pipelines. And you will be able to assess results, trends, technologies, therapies and future business op …
